Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Mesothelioma × Axitinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Other solid neoplasm 1

Conditions

Carcinoma, Renal Cell 64 Kidney Neoplasms 17 Neoplasms 16 Carcinoma, Non-Small-Cell Lung 10 Neoplasm Metastasis 9 Colorectal Neoplasms 8 Carcinoma, Hepatocellular 8 Melanoma 7 Carcinoma 7 Glioblastoma 5 Lung Neoplasms 4 Clear-cell metastatic renal cell carcinoma 4 Uterine Cervical Neoplasms 3 Recurrence 3 Ovarian Neoplasms 3 Endometrial Neoplasms 3 Thyroid Neoplasms 2 Stomach Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Solid Tumors 2 Skin Neoplasms 2 Sarcoma 2 Pheochromocytoma 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Paraganglioma 2 Liver Neoplasms 2 Kidney Diseases 2 Carcinoma, Adenoid Cystic 2 Breast Neoplasms 2 Advanced Solid Tumors 2

Interventions

Pemetrexed 40 Cisplatin 35 pembrolizumab 21 Nivolumab 16 Carboplatin 16 Ipilimumab 12 Gemcitabine 9 Cyclophosphamide 9 fludarabine 6 durvalumab 6 Bevacizumab 6 Radiotherapy, Intensity-Modulated 4 LMB-100 4 Drug Therapy 4 Dexamethasone 4 tremelimumab 3 tazemetostat 3 spartalizumab 3 olaparib 3 niraparib 3 atezolizumab 3 anetumab ravtansine 3 amatuximab 3 Vinorelbine 3 Paclitaxel 3 Oxaliplatin 3 Imatinib Mesylate 3 Fluorouracil 3 Cerebral Decortication 3 Blood Specimen Collection 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01211275 2017-02-28

N08CPA

The Netherlands Cancer Institute

Phase 1/2 Completed

Other solid neoplasmThoracic

Mesothelioma, Malignant, Mesothelioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡